| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | excitatory extracellular ligand-gated monoatomic ion channel activity | 1.20e-05 | 43 | 21 | 3 | GO:0005231 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 2.83e-05 | 57 | 21 | 3 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 3.30e-05 | 60 | 21 | 3 | GO:0099529 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 4.20e-05 | 65 | 21 | 3 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 4.20e-05 | 65 | 21 | 3 | GO:0022824 | |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 6.45e-05 | 75 | 21 | 3 | GO:0098960 | |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 6.98e-05 | 77 | 21 | 3 | GO:0005230 | |
| GeneOntologyMolecularFunction | acetylcholine binding | 8.16e-05 | 13 | 21 | 2 | GO:0042166 | |
| GeneOntologyMolecularFunction | chloride channel regulator activity | 1.10e-04 | 15 | 21 | 2 | GO:0017081 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 1.22e-04 | 93 | 21 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | adenylate cyclase binding | 1.25e-04 | 16 | 21 | 2 | GO:0008179 | |
| GeneOntologyMolecularFunction | acetylcholine-gated monoatomic cation-selective channel activity | 1.42e-04 | 17 | 21 | 2 | GO:0022848 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 1.52e-04 | 100 | 21 | 3 | GO:0030594 | |
| GeneOntologyMolecularFunction | toxic substance binding | 1.60e-04 | 18 | 21 | 2 | GO:0015643 | |
| GeneOntologyMolecularFunction | acetylcholine receptor activity | 2.63e-04 | 23 | 21 | 2 | GO:0015464 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 4.09e-04 | 140 | 21 | 3 | GO:0099094 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.04e-03 | 193 | 21 | 3 | GO:0015276 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.10e-03 | 197 | 21 | 3 | GO:0022834 | |
| GeneOntologyMolecularFunction | protein dimerization activity | 1.18e-03 | 1205 | 21 | 6 | GO:0046983 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides | 3.25e-03 | 81 | 21 | 2 | GO:0016811 | |
| GeneOntologyMolecularFunction | gated channel activity | 4.93e-03 | 334 | 21 | 3 | GO:0022836 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 5.09e-03 | 102 | 21 | 2 | GO:0001540 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 5.31e-03 | 343 | 21 | 3 | GO:0005261 | |
| GeneOntologyMolecularFunction | ATPase binding | 5.69e-03 | 108 | 21 | 2 | GO:0051117 | |
| GeneOntologyMolecularFunction | calcium channel activity | 8.03e-03 | 129 | 21 | 2 | GO:0005262 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 9.47e-03 | 815 | 21 | 4 | GO:0042803 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds | 1.02e-02 | 146 | 21 | 2 | GO:0016810 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.09e-02 | 151 | 21 | 2 | GO:0015085 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | 1.18e-02 | 459 | 21 | 3 | GO:0005216 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.24e-02 | 162 | 21 | 2 | GO:0099106 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 9.87e-07 | 2 | 21 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid-beta formation | 1.59e-06 | 23 | 21 | 3 | GO:1902004 | |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 2.96e-06 | 3 | 21 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | positive regulation of amyloid precursor protein catabolic process | 3.27e-06 | 29 | 21 | 3 | GO:1902993 | |
| GeneOntologyBiologicalProcess | generation of ovulation cycle rhythm | 5.92e-06 | 4 | 21 | 2 | GO:0060112 | |
| GeneOntologyBiologicalProcess | positive regulation of amide metabolic process | 6.91e-06 | 37 | 21 | 3 | GO:0034250 | |
| GeneOntologyBiologicalProcess | sensory processing | 9.85e-06 | 5 | 21 | 2 | GO:0050893 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback | 1.48e-05 | 6 | 21 | 2 | GO:0001978 | |
| GeneOntologyBiologicalProcess | regulation of amyloid-beta formation | 1.73e-05 | 50 | 21 | 3 | GO:1902003 | |
| GeneOntologyBiologicalProcess | response to cold | 1.95e-05 | 52 | 21 | 3 | GO:0009409 | |
| GeneOntologyBiologicalProcess | cellular response to acetylcholine | 2.06e-05 | 53 | 21 | 3 | GO:1905145 | |
| GeneOntologyBiologicalProcess | response to acetylcholine | 2.44e-05 | 56 | 21 | 3 | GO:1905144 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | 2.68e-05 | 175 | 21 | 4 | GO:0031644 | |
| GeneOntologyBiologicalProcess | regulation of systemic arterial blood pressure by baroreceptor feedback | 2.75e-05 | 8 | 21 | 2 | GO:0003025 | |
| GeneOntologyBiologicalProcess | regulation of amyloid precursor protein catabolic process | 2.85e-05 | 59 | 21 | 3 | GO:1902991 | |
| GeneOntologyBiologicalProcess | amyloid-beta formation | 2.85e-05 | 59 | 21 | 3 | GO:0034205 | |
| GeneOntologyBiologicalProcess | positive regulation of CoA-transferase activity | 3.54e-05 | 9 | 21 | 2 | GO:1905920 | |
| GeneOntologyBiologicalProcess | modulation of excitatory postsynaptic potential | 3.81e-05 | 65 | 21 | 3 | GO:0098815 | |
| GeneOntologyBiologicalProcess | presynaptic modulation of chemical synaptic transmission | 4.18e-05 | 67 | 21 | 3 | GO:0099171 | |
| GeneOntologyBiologicalProcess | amyloid-beta metabolic process | 4.56e-05 | 69 | 21 | 3 | GO:0050435 | |
| GeneOntologyBiologicalProcess | regulation of CoA-transferase activity | 5.40e-05 | 11 | 21 | 2 | GO:1905918 | |
| GeneOntologyBiologicalProcess | behavioral response to nicotine | 5.40e-05 | 11 | 21 | 2 | GO:0035095 | |
| GeneOntologyBiologicalProcess | amyloid precursor protein catabolic process | 5.40e-05 | 73 | 21 | 3 | GO:0042987 | |
| GeneOntologyBiologicalProcess | regulation of synapse structural plasticity | 6.48e-05 | 12 | 21 | 2 | GO:0051823 | |
| GeneOntologyBiologicalProcess | regulation of system process | 6.83e-05 | 734 | 21 | 6 | GO:0044057 | |
| GeneOntologyBiologicalProcess | regulation of synaptic transmission, dopaminergic | 7.65e-05 | 13 | 21 | 2 | GO:0032225 | |
| GeneOntologyBiologicalProcess | regulation of amide metabolic process | 9.44e-05 | 88 | 21 | 3 | GO:0034248 | |
| GeneOntologyBiologicalProcess | dendrite arborization | 1.03e-04 | 15 | 21 | 2 | GO:0140059 | |
| GeneOntologyBiologicalProcess | regulation of heart contraction | 1.06e-04 | 249 | 21 | 4 | GO:0008016 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 1.33e-04 | 17 | 21 | 2 | GO:0048149 | |
| GeneOntologyBiologicalProcess | amyloid precursor protein metabolic process | 1.42e-04 | 101 | 21 | 3 | GO:0042982 | |
| GeneOntologyBiologicalProcess | regulation of amyloid fibril formation | 1.67e-04 | 19 | 21 | 2 | GO:1905906 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell development | 1.86e-04 | 20 | 21 | 2 | GO:1901550 | |
| GeneOntologyBiologicalProcess | regulation of establishment of endothelial barrier | 1.86e-04 | 20 | 21 | 2 | GO:1903140 | |
| GeneOntologyBiologicalProcess | regulation of response to drug | 2.05e-04 | 21 | 21 | 2 | GO:2001023 | |
| GeneOntologyBiologicalProcess | heart contraction | 2.10e-04 | 298 | 21 | 4 | GO:0060047 | |
| GeneOntologyBiologicalProcess | heart process | 2.42e-04 | 309 | 21 | 4 | GO:0003015 | |
| GeneOntologyBiologicalProcess | regulation of amine transport | 2.67e-04 | 125 | 21 | 3 | GO:0051952 | |
| GeneOntologyBiologicalProcess | nervous system process involved in regulation of systemic arterial blood pressure | 2.69e-04 | 24 | 21 | 2 | GO:0001976 | |
| GeneOntologyBiologicalProcess | regulation of heart rate | 2.93e-04 | 129 | 21 | 3 | GO:0002027 | |
| GeneOntologyBiologicalProcess | regulation of blood circulation | 2.96e-04 | 326 | 21 | 4 | GO:1903522 | |
| GeneOntologyBiologicalProcess | excitatory postsynaptic potential | 2.99e-04 | 130 | 21 | 3 | GO:0060079 | |
| GeneOntologyBiologicalProcess | regulation of norepinephrine secretion | 3.16e-04 | 26 | 21 | 2 | GO:0014061 | |
| GeneOntologyBiologicalProcess | amine transport | 3.49e-04 | 137 | 21 | 3 | GO:0015837 | |
| GeneOntologyBiologicalProcess | norepinephrine secretion | 3.67e-04 | 28 | 21 | 2 | GO:0048243 | |
| GeneOntologyBiologicalProcess | positive regulation of systemic arterial blood pressure | 3.67e-04 | 28 | 21 | 2 | GO:0003084 | |
| GeneOntologyBiologicalProcess | blood circulation | 4.04e-04 | 648 | 21 | 5 | GO:0008015 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission, postsynaptic | 4.29e-04 | 147 | 21 | 3 | GO:0099565 | |
| GeneOntologyBiologicalProcess | positive regulation of long-term synaptic potentiation | 5.43e-04 | 34 | 21 | 2 | GO:1900273 | |
| GeneOntologyBiologicalProcess | thyroid gland development | 5.43e-04 | 34 | 21 | 2 | GO:0030878 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate | 5.76e-04 | 35 | 21 | 2 | GO:0010460 | |
| GeneOntologyBiologicalProcess | synaptic transmission, dopaminergic | 5.76e-04 | 35 | 21 | 2 | GO:0001963 | |
| GeneOntologyBiologicalProcess | neuron projection arborization | 6.79e-04 | 38 | 21 | 2 | GO:0140058 | |
| GeneOntologyBiologicalProcess | norepinephrine transport | 6.79e-04 | 38 | 21 | 2 | GO:0015874 | |
| GeneOntologyBiologicalProcess | circulatory system process | 7.08e-04 | 733 | 21 | 5 | GO:0003013 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic membrane potential | 7.74e-04 | 180 | 21 | 3 | GO:0060078 | |
| GeneOntologyBiologicalProcess | positive regulation of excitatory postsynaptic potential | 8.69e-04 | 43 | 21 | 2 | GO:2000463 | |
| GeneOntologyBiologicalProcess | synaptic transmission, cholinergic | 9.10e-04 | 44 | 21 | 2 | GO:0007271 | |
| GeneOntologyBiologicalProcess | amyloid fibril formation | 9.52e-04 | 45 | 21 | 2 | GO:1990000 | |
| GeneOntologyBiologicalProcess | dendrite morphogenesis | 1.02e-03 | 198 | 21 | 3 | GO:0048813 | |
| GeneOntologyBiologicalProcess | action potential | 1.07e-03 | 201 | 21 | 3 | GO:0001508 | |
| GeneOntologyBiologicalProcess | adult behavior | 1.10e-03 | 203 | 21 | 3 | GO:0030534 | |
| GeneOntologyBiologicalProcess | positive regulation of heart contraction | 1.13e-03 | 49 | 21 | 2 | GO:0045823 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 beta production | 1.17e-03 | 50 | 21 | 2 | GO:0032691 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 1.18e-03 | 208 | 21 | 3 | GO:0009266 | |
| GeneOntologyBiologicalProcess | acetylcholine receptor signaling pathway | 1.22e-03 | 51 | 21 | 2 | GO:0095500 | |
| GeneOntologyBiologicalProcess | positive regulation of blood circulation | 1.32e-03 | 53 | 21 | 2 | GO:1903524 | |
| GeneOntologyBiologicalProcess | establishment of endothelial barrier | 1.58e-03 | 58 | 21 | 2 | GO:0061028 | |
| GeneOntologyBiologicalProcess | response to food | 1.58e-03 | 58 | 21 | 2 | GO:0032094 | |
| GeneOntologyBiologicalProcess | response to nicotine | 1.58e-03 | 58 | 21 | 2 | GO:0035094 | |
| GeneOntologyBiologicalProcess | amide metabolic process | 1.59e-03 | 511 | 21 | 4 | GO:0043603 | |
| GeneOntologyBiologicalProcess | negative regulation of protein modification process | 1.61e-03 | 512 | 21 | 4 | GO:0031400 | |
| GeneOntologyBiologicalProcess | positive regulation of synaptic transmission | 1.63e-03 | 233 | 21 | 3 | GO:0050806 | |
| GeneOntologyBiologicalProcess | positive regulation of blood pressure | 1.63e-03 | 59 | 21 | 2 | GO:0045777 | |
| GeneOntologyBiologicalProcess | response to amyloid-beta | 1.74e-03 | 61 | 21 | 2 | GO:1904645 | |
| GeneOntologyBiologicalProcess | negative regulation of inflammatory response | 1.75e-03 | 239 | 21 | 3 | GO:0050728 | |
| GeneOntologyBiologicalProcess | neuronal action potential | 1.86e-03 | 63 | 21 | 2 | GO:0019228 | |
| GeneOntologyBiologicalProcess | regulation of catecholamine secretion | 2.10e-03 | 67 | 21 | 2 | GO:0050433 | |
| GeneOntologyBiologicalProcess | regulation of long-term synaptic potentiation | 2.10e-03 | 67 | 21 | 2 | GO:1900271 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 2.10e-03 | 67 | 21 | 2 | GO:0045601 | |
| GeneOntologyBiologicalProcess | ovulation cycle process | 2.16e-03 | 68 | 21 | 2 | GO:0022602 | |
| GeneOntologyBiologicalProcess | regulation of membrane potential | 2.21e-03 | 559 | 21 | 4 | GO:0042391 | |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 2.22e-03 | 69 | 21 | 2 | GO:0098926 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 2.42e-03 | 72 | 21 | 2 | GO:0032692 | |
| GeneOntologyBiologicalProcess | catecholamine secretion | 2.90e-03 | 79 | 21 | 2 | GO:0050432 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-6 production | 2.97e-03 | 80 | 21 | 2 | GO:0032715 | |
| GeneOntologyBiologicalProcess | endothelial cell development | 2.97e-03 | 80 | 21 | 2 | GO:0001885 | |
| GeneOntologyCellularComponent | spine apparatus membrane | 2.88e-06 | 3 | 21 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | spine apparatus | 3.45e-05 | 9 | 21 | 2 | GO:0097444 | |
| GeneOntologyCellularComponent | acetylcholine-gated channel complex | 1.46e-04 | 18 | 21 | 2 | GO:0005892 | |
| GeneOntologyCellularComponent | glycinergic synapse | 1.81e-04 | 20 | 21 | 2 | GO:0098690 | |
| GeneOntologyCellularComponent | axolemma | 2.00e-04 | 21 | 21 | 2 | GO:0030673 | |
| GeneOntologyCellularComponent | cholinergic synapse | 2.19e-04 | 22 | 21 | 2 | GO:0098981 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | 1.03e-03 | 201 | 21 | 3 | GO:0099634 | |
| GeneOntologyCellularComponent | asymmetric synapse | 1.18e-03 | 477 | 21 | 4 | GO:0032279 | |
| GeneOntologyCellularComponent | postsynaptic specialization | 1.43e-03 | 503 | 21 | 4 | GO:0099572 | |
| GeneOntologyCellularComponent | neuron to neuron synapse | 1.65e-03 | 523 | 21 | 4 | GO:0098984 | |
| GeneOntologyCellularComponent | dendritic shaft | 2.49e-03 | 74 | 21 | 2 | GO:0043198 | |
| GeneOntologyCellularComponent | presynaptic membrane | 2.57e-03 | 277 | 21 | 3 | GO:0042734 | |
| GeneOntologyCellularComponent | neuron projection membrane | 3.04e-03 | 82 | 21 | 2 | GO:0032589 | |
| GeneOntologyCellularComponent | main axon | 3.57e-03 | 89 | 21 | 2 | GO:0044304 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 4.95e-03 | 350 | 21 | 3 | GO:0098802 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 6.13e-03 | 378 | 21 | 3 | GO:0034702 | |
| GeneOntologyCellularComponent | postsynaptic membrane | 7.41e-03 | 405 | 21 | 3 | GO:0045211 | |
| MousePheno | airway basal cell hyperplasia | 1.39e-06 | 2 | 17 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 1.39e-06 | 2 | 17 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 1.39e-06 | 2 | 17 | 2 | MP:0011113 | |
| MousePheno | abnormal nicotine-mediated receptor currents | 8.34e-06 | 4 | 17 | 2 | MP:0009475 | |
| MousePheno | prolonged estrous cycle | 1.33e-05 | 39 | 17 | 3 | MP:0009006 | |
| MousePheno | failure of neuromuscular synapse presynaptic differentiation | 2.08e-05 | 6 | 17 | 2 | MP:0001054 | |
| MousePheno | abnormal GABAergic neuron physiology | 3.88e-05 | 8 | 17 | 2 | MP:0011987 | |
| MousePheno | impaired spatial working memory | 9.12e-05 | 12 | 17 | 2 | MP:0014370 | |
| MousePheno | decreased erythroblast number | 9.12e-05 | 12 | 17 | 2 | MP:0011179 | |
| MousePheno | abnormal GABA-mediated receptor currents | 2.11e-04 | 18 | 17 | 2 | MP:0004008 | |
| MousePheno | decreased CNS synapse formation | 3.17e-04 | 22 | 17 | 2 | MP:0004998 | |
| MousePheno | abnormal suckling behavior | 3.22e-04 | 113 | 17 | 3 | MP:0001436 | |
| MousePheno | reduced female fertility | 3.77e-04 | 296 | 17 | 4 | MP:0001923 | |
| MousePheno | abnormal estrous cycle | 3.84e-04 | 120 | 17 | 3 | MP:0001927 | |
| MousePheno | abnormal GABAergic neuron morphology | 4.11e-04 | 25 | 17 | 2 | MP:0003245 | |
| MousePheno | taste/olfaction phenotype | 4.33e-04 | 125 | 17 | 3 | MP:0005394 | |
| MousePheno | abnormal ovulation cycle | 4.43e-04 | 126 | 17 | 3 | MP:0009344 | |
| MousePheno | impaired olfaction | 5.54e-04 | 29 | 17 | 2 | MP:0008544 | |
| MousePheno | abnormal eating behavior | 5.94e-04 | 604 | 17 | 5 | MP:0001431 | |
| MousePheno | abnormal cerebral cortex pyramidal cell morphology | 6.76e-04 | 32 | 17 | 2 | MP:0009969 | |
| MousePheno | abnormal somatosensory cortex morphology | 7.19e-04 | 33 | 17 | 2 | MP:0000859 | |
| MousePheno | abnormal CNS synapse formation | 8.09e-04 | 35 | 17 | 2 | MP:0004996 | |
| MousePheno | abnormal erythroblast number | 8.09e-04 | 35 | 17 | 2 | MP:0011177 | |
| MousePheno | abnormal parietal lobe morphology | 9.04e-04 | 37 | 17 | 2 | MP:0000794 | |
| MousePheno | abnormal brain interneuron morphology | 9.04e-04 | 37 | 17 | 2 | MP:0004101 | |
| MousePheno | decreased litter size | 9.66e-04 | 380 | 17 | 4 | MP:0001935 | |
| MousePheno | abnormal consumption behavior | 1.12e-03 | 695 | 17 | 5 | MP:0002069 | |
| MousePheno | abnormal litter size | 1.16e-03 | 399 | 17 | 4 | MP:0001933 | |
| MousePheno | abnormal erythroblast morphology | 1.34e-03 | 45 | 17 | 2 | MP:0011176 | |
| MousePheno | abnormal olfaction | 1.65e-03 | 50 | 17 | 2 | MP:0001984 | |
| Domain | - | 3.00e-04 | 23 | 21 | 2 | 1.20.120.370 | |
| Domain | Acetylcholine_rcpt_TM | 3.00e-04 | 23 | 21 | 2 | IPR027361 | |
| Domain | bHLH_dom | 3.01e-04 | 118 | 21 | 3 | IPR011598 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.16e-03 | 45 | 21 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 1.21e-03 | 46 | 21 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 1.26e-03 | 47 | 21 | 2 | PF02931 | |
| Domain | Neur_channel | 1.26e-03 | 47 | 21 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 1.26e-03 | 47 | 21 | 2 | IPR006202 | |
| Domain | Neurotrans-gated_channel_TM | 1.26e-03 | 47 | 21 | 2 | IPR006029 | |
| Domain | NEUROTR_ION_CHANNEL | 1.26e-03 | 47 | 21 | 2 | PS00236 | |
| Domain | - | 1.26e-03 | 47 | 21 | 2 | 2.70.170.10 | |
| Domain | - | 6.59e-03 | 109 | 21 | 2 | 4.10.280.10 | |
| Domain | HLH | 6.83e-03 | 111 | 21 | 2 | PF00010 | |
| Domain | HLH | 7.43e-03 | 116 | 21 | 2 | SM00353 | |
| Domain | BHLH | 7.56e-03 | 117 | 21 | 2 | PS50888 | |
| Pathway | REACTOME_HIGHLY_CALCIUM_PERMEABLE_POSTSYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | 7.92e-05 | 12 | 16 | 2 | MM15312 | |
| Pathway | REACTOME_ACETYLCHOLINE_BINDING_AND_DOWNSTREAM_EVENTS | 1.26e-04 | 15 | 16 | 2 | MM14704 | |
| Pathway | WP_15Q133_COPY_NUMBER_VARIATION_SYNDROME | 3.01e-04 | 23 | 16 | 2 | M39883 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 5.30e-04 | 144 | 16 | 3 | MM14501 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 38822526 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 38070724 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19626424 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17012698 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 38253622 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20595621 | ||
| Pubmed | Cholinergic Pathway Suppresses Pulmonary Innate Immunity Facilitating Pneumonia After Stroke. | 3.47e-07 | 2 | 21 | 2 | 26451017 | |
| Pubmed | Nicotine stimulates nerve growth factor in lung fibroblasts through an NFκB-dependent mechanism. | 3.47e-07 | 2 | 21 | 2 | 25296021 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 34514543 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 34453977 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 24757672 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 26999808 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 22183893 | ||
| Pubmed | Delayed procedural learning in α7-nicotinic acetylcholine receptor knockout mice. | 3.47e-07 | 2 | 21 | 2 | 21679297 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 27129924 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17291692 | ||
| Pubmed | Sensorimotor gating and spatial learning in α7-nicotinic receptor knockout mice. | 3.47e-07 | 2 | 21 | 2 | 23521765 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17462791 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 28258105 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 15555774 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 9364063 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19344760 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 35100606 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 12606407 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 8804729 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 35926661 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17640819 | ||
| Pubmed | Genetic variations in CHRNA7 or CHRFAM7 and susceptibility to dementia. | 3.47e-07 | 2 | 21 | 2 | 22300029 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 16545784 | ||
| Pubmed | Lung epithelial response to cigarette smoke and modulation by the nicotinic alpha 7 receptor. | 3.47e-07 | 2 | 21 | 2 | 29117258 | |
| Pubmed | Contribution of α7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. | 3.47e-07 | 2 | 21 | 2 | 23431157 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 18627272 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 29114104 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 32018068 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 26206074 | ||
| Pubmed | Nicotine elicits prolonged calcium signaling along ventral hippocampal axons. | 3.47e-07 | 2 | 21 | 2 | 24349346 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 33995108 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 32552811 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21143250 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 28551099 | ||
| Pubmed | Cholinergic modulation of appetite-related synapses in mouse lateral hypothalamic slice. | 3.47e-07 | 2 | 21 | 2 | 16319313 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 24836856 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 31904546 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 16785311 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 15948184 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 35678315 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 11409732 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 33117372 | ||
| Pubmed | Impaired synaptic plasticity in the visual cortex of mice lacking α7-nicotinic receptor subunit. | 3.47e-07 | 2 | 21 | 2 | 25797465 | |
| Pubmed | Functional role of alpha7 nicotinic receptor in physiological control of cutaneous homeostasis. | 3.47e-07 | 2 | 21 | 2 | 12628457 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 25157794 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19615981 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 27874086 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 38944290 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 29197398 | ||
| Pubmed | Nicotine withdrawal-induced inattention is absent in alpha7 nAChR knockout mice. | 3.47e-07 | 2 | 21 | 2 | 28243714 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 38178134 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 31202708 | ||
| Pubmed | Prenatal nicotine exposure alters lung function and airway geometry through α7 nicotinic receptors. | 3.47e-07 | 2 | 21 | 2 | 22246862 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17218065 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 24298024 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 23325242 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 29975102 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 29580318 | ||
| Pubmed | Glutamatergic synapse formation is promoted by α7-containing nicotinic acetylcholine receptors. | 3.47e-07 | 2 | 21 | 2 | 22649244 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 35479080 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20713028 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17898229 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 24811002 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 38597441 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21901321 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 27471776 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17935702 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 22688057 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 24983521 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 22820264 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 33953172 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 32028688 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20624304 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21784975 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 30089821 | ||
| Pubmed | Nicotinic acetylcholine receptor activation reduces skeletal muscle inflammation of mdx mice. | 3.47e-07 | 2 | 21 | 2 | 20615555 | |
| Pubmed | Nicotine physical dependence in the mouse: involvement of the alpha7 nicotinic receptor subtype. | 3.47e-07 | 2 | 21 | 2 | 15896732 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20659128 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 20843956 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 10800961 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 30429582 | ||
| Pubmed | A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons. | 3.47e-07 | 2 | 21 | 2 | 21501254 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 24381265 | ||
| Pubmed | α7-cholinergic receptor mediates vagal induction of splenic norepinephrine. | 3.47e-07 | 2 | 21 | 2 | 21339364 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21368056 | ||
| Pubmed | Genetic variation within the Chrna7 gene modulates nicotine reward-like phenotypes in mice. | 3.47e-07 | 2 | 21 | 2 | 24289814 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 19949071 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 1400473 | ||
| Pubmed | Characterization of allelic variants at chromosome 15q14 in schizophrenia. | 3.47e-07 | 2 | 21 | 2 | 16417613 | |
| Pubmed | Dynamic Impairment of Olfactory Behavior and Signaling Mediated by an Olfactory Corticofugal System. | 3.47e-07 | 2 | 21 | 2 | 32817250 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 17204496 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 11834293 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 21437621 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 26937017 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q13 | 9.60e-04 | 100 | 21 | 2 | chr15q13 | |
| GeneFamily | Basic helix-loop-helix proteins | 2.74e-03 | 110 | 13 | 2 | 420 | |
| Coexpression | HEVNER_SUBPLATE_PROJECTION_NEURONS | 4.02e-05 | 12 | 21 | 2 | MM416 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_TNFAIP8L3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.92e-05 | 163 | 21 | 3 | 7352c30c253f69f65dcb15f46f9c87719741b55b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.59e-05 | 169 | 21 | 3 | f47c4fbdc2a38745ec1b35104b85121c1413875a | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.06e-05 | 173 | 21 | 3 | af85fb9f6e26a044ca4d23e5872039b1a7b73b1b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.06e-05 | 173 | 21 | 3 | 0ba64e5385fe714f876002520f8b5202809bf11e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1-3_VIP_SSTR1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.56e-05 | 177 | 21 | 3 | fdab7b7ddfb06f913b8224c0c80574dc3cf4cbd4 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 178 | 21 | 3 | 08b4a497aca0aeabf4f6a8a55c05b56417b69e78 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.68e-05 | 178 | 21 | 3 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 179 | 21 | 3 | 97ba67a856680f24846244c0b92c886cc0e79537 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.81e-05 | 179 | 21 | 3 | c7afbd10072d36a35cd20ae73670d76b9cefd22d | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.94e-05 | 180 | 21 | 3 | 392bc71a69653ba12de31bed4e9357f181094641 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 181 | 21 | 3 | 8fd64404e57c22c204d835fc5626f73554257b19 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 181 | 21 | 3 | 03a303cd2f366f09c18b118bbba6f5e3f95ad56c | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.07e-05 | 181 | 21 | 3 | 2f3d04d22d4ac016e61709ea5af3d48885c946c4 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.21e-05 | 182 | 21 | 3 | 7dc61e901428cea04f00ebb0939a44d21a6145c6 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.34e-05 | 183 | 21 | 3 | 6e6128c5be5e0a2db6d84eecbf4dddd02d0216f8 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.34e-05 | 183 | 21 | 3 | 5e361be3ae3fe05098968e58427630127bd12675 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.34e-05 | 183 | 21 | 3 | e3ffef2b57dc5b96466dccc9cd54ba326ccf378a | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.61e-05 | 185 | 21 | 3 | 16e9ccea0e3b95d90dc48ef74206c805681dac0b | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.61e-05 | 185 | 21 | 3 | 027020754dbf71b0034791f9a34ae795e3b85f81 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.61e-05 | 185 | 21 | 3 | 08fad1e3c3cc5f1c3eb6629a49c094b628e75a92 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.61e-05 | 185 | 21 | 3 | bdfa8c284bbc5e85c806327fbb7778cf16242a38 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.61e-05 | 185 | 21 | 3 | 487fa382232564f075960899d50afa0edae5d258 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.61e-05 | 185 | 21 | 3 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-05 | 187 | 21 | 3 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_ADARB2_ADAM33|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.89e-05 | 187 | 21 | 3 | 02105c82a9ba79d2f19e002188377fc3440770c2 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.03e-05 | 188 | 21 | 3 | ee572246e0c2f41bdbc29a03edc67b831af95c09 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.62e-05 | 192 | 21 | 3 | 3abee376c37c3646da33ac381aa63d50a01607a6 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 53d5e427f0cbf5cf0b63efe4ec01da302f555704 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | c1797542541747b524c9c22c723d24c8d027d486 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | d0167f96314be78b6d867bbcc6e4396071d931b8 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-SST-MC4R-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | a0cc84add181109bb66ba9d49c732e1790222c96 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | c74bc12e13d002dedaaf75a2244ec111e47524e1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 8a8f9d9e5ffab3f736c4bd0a5bb616d442d137d1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-CDH12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | ead9eb579bb25fde05fc15602e3d05ab6617f7ac | |
| Drug | alpha-conotoxin ImI | 1.18e-06 | 23 | 21 | 3 | CID000133011 | |
| Drug | AC1L2IZE | 1.35e-06 | 24 | 21 | 3 | CID000072928 | |
| Drug | PhTX-343 | 4.73e-06 | 36 | 21 | 3 | CID000159548 | |
| Drug | dihydro-beta-erythroidine | 8.74e-06 | 44 | 21 | 3 | CID000031762 | |
| Drug | philanthotoxin | 9.36e-06 | 45 | 21 | 3 | CID000115201 | |
| Drug | NSC624746 | 1.92e-05 | 57 | 21 | 3 | CID000107640 | |
| Drug | Tubocurarine,d | 3.87e-05 | 72 | 21 | 3 | CID000001210 | |
| Drug | eserine hemisulfate | 4.20e-05 | 74 | 21 | 3 | CID000004811 | |
| Drug | Dns-C6-Cho | 4.43e-05 | 11 | 21 | 2 | CID000124728 | |
| Drug | AC1L9NC9 | 4.43e-05 | 11 | 21 | 2 | CID000449642 | |
| Drug | dihydronereistoxin | 4.43e-05 | 11 | 21 | 2 | CID000121232 | |
| Drug | bipinnatin-B | 4.43e-05 | 11 | 21 | 2 | CID000127363 | |
| Drug | LJP 1082 | 4.43e-05 | 11 | 21 | 2 | CID003037609 | |
| Drug | topiramate | 4.55e-05 | 76 | 21 | 3 | ctd:C052342 | |
| Drug | AC1L9P8C | 5.32e-05 | 12 | 21 | 2 | CID000450864 | |
| Drug | SureCN373116 | 5.32e-05 | 12 | 21 | 2 | CID010085732 | |
| Drug | nereistoxin | 6.28e-05 | 13 | 21 | 2 | CID000015401 | |
| Drug | 1-acetyl-4-methylpiperazine methiodide | 6.28e-05 | 13 | 21 | 2 | CID004392675 | |
| Drug | C-toxiferine-I | 6.28e-05 | 13 | 21 | 2 | CID005089093 | |
| Drug | bipinnatin-C | 6.28e-05 | 13 | 21 | 2 | CID000129977 | |
| Drug | bipinnatin-A | 6.28e-05 | 13 | 21 | 2 | CID000196603 | |
| Drug | memantine | 6.59e-05 | 86 | 21 | 3 | CID000004054 | |
| Drug | cloricromene | 6.82e-05 | 87 | 21 | 3 | CID000068876 | |
| Drug | mecamylamine | 7.30e-05 | 89 | 21 | 3 | CID000004032 | |
| Drug | 2,3-dichlorooctafluorobutane | 7.32e-05 | 14 | 21 | 2 | CID000078982 | |
| Drug | LNF 209 | 7.32e-05 | 14 | 21 | 2 | CID000132666 | |
| Drug | soman | 8.06e-05 | 92 | 21 | 3 | CID000007305 | |
| Drug | aa373 | 8.45e-05 | 15 | 21 | 2 | CID000191672 | |
| Drug | (-)-pictamine | 8.45e-05 | 15 | 21 | 2 | CID006918623 | |
| Drug | (-)-lepadin B | 8.45e-05 | 15 | 21 | 2 | CID006918624 | |
| Drug | SAD-128 | 8.45e-05 | 15 | 21 | 2 | CID000162008 | |
| Drug | anatoxin-a hydrochloride | 8.45e-05 | 15 | 21 | 2 | CID000135265 | |
| Drug | UB-165 | 8.45e-05 | 15 | 21 | 2 | CID004694339 | |
| Drug | N-methylcytisine | 8.45e-05 | 15 | 21 | 2 | CID000234566 | |
| Drug | ketamine | 8.79e-05 | 262 | 21 | 4 | CID000003821 | |
| Drug | AC1L2SVN | 9.65e-05 | 16 | 21 | 2 | CID000127922 | |
| Drug | benzoquinonium | 9.65e-05 | 16 | 21 | 2 | CID000009393 | |
| Drug | 3-(trifluoromethyl)-3-(m-iodophenyl)diazirine | 9.65e-05 | 16 | 21 | 2 | CID000123866 | |
| Drug | PNU-282,987 | 9.65e-05 | 16 | 21 | 2 | CID004655349 | |
| Drug | Nsc36388 | 1.09e-04 | 17 | 21 | 2 | CID000014954 | |
| Drug | H-8105 | 1.17e-04 | 282 | 21 | 4 | CID000164531 | |
| Drug | ABT-594 | 1.23e-04 | 18 | 21 | 2 | CID003075702 | |
| Drug | AC1O8PVM | 1.23e-04 | 18 | 21 | 2 | CID000004989 | |
| Drug | 5-fluoromethylornithine | 1.23e-04 | 18 | 21 | 2 | CID000119351 | |
| Drug | AC1L1J48 | 1.23e-04 | 18 | 21 | 2 | CID000004859 | |
| Drug | AC1LCVGE | 1.23e-04 | 18 | 21 | 2 | CID000656712 | |
| Drug | benzetimide | 1.23e-04 | 18 | 21 | 2 | CID000021846 | |
| Drug | norethisterone oenanthate | 1.33e-04 | 109 | 21 | 3 | CID000019688 | |
| Drug | isoarecolone | 1.37e-04 | 19 | 21 | 2 | CID000146970 | |
| Drug | beta-erythroidine | 1.37e-04 | 19 | 21 | 2 | CID000010074 | |
| Drug | AC1L9P88 | 1.37e-04 | 19 | 21 | 2 | CID000450860 | |
| Drug | perhydrohistrionicotoxin | 1.37e-04 | 19 | 21 | 2 | CID000107881 | |
| Drug | PNU-120596 | 1.37e-04 | 19 | 21 | 2 | CID000311434 | |
| Drug | 4-(N-maleimido)benzyltrimethylammonium | 1.37e-04 | 19 | 21 | 2 | CID000162425 | |
| Drug | guanethidine | 1.48e-04 | 113 | 21 | 3 | CID000003518 | |
| Drug | AC1Q5X7V | 1.52e-04 | 20 | 21 | 2 | CID000050190 | |
| Drug | 3-(2-azetidinylmethoxy)pyridine | 1.52e-04 | 20 | 21 | 2 | CID000001962 | |
| Drug | Dichloride, Alcuronium | 1.52e-04 | 20 | 21 | 2 | CID003032788 | |
| Drug | dinotefuran | 1.68e-04 | 21 | 21 | 2 | CID000197701 | |
| Drug | meproadifen | 1.68e-04 | 21 | 21 | 2 | CID000189752 | |
| Drug | suberyldicholine | 1.85e-04 | 22 | 21 | 2 | CID000123989 | |
| Drug | clothianidin | 1.85e-04 | 22 | 21 | 2 | CID000213027 | |
| Drug | AR-R17779 | 1.85e-04 | 22 | 21 | 2 | CID005310971 | |
| Drug | histrionicotoxin | 1.85e-04 | 22 | 21 | 2 | CID005282247 | |
| Drug | kynurenic acid | 1.86e-04 | 122 | 21 | 3 | CID000003845 | |
| Drug | choline | 1.90e-04 | 320 | 21 | 4 | CID000000305 | |
| Drug | ABT-418 | 2.03e-04 | 23 | 21 | 2 | CID000119380 | |
| Drug | AC1L3BL8 | 2.03e-04 | 23 | 21 | 2 | CID000086457 | |
| Drug | alpha-conotoxin SI | 2.03e-04 | 23 | 21 | 2 | CID000163979 | |
| Drug | Skpymrfamide | 2.03e-04 | 23 | 21 | 2 | CID000132661 | |
| Drug | CID6325740 | 2.03e-04 | 23 | 21 | 2 | CID006325740 | |
| Drug | CNQX | 2.05e-04 | 126 | 21 | 3 | CID000002821 | |
| Drug | AP-5 | 2.14e-04 | 128 | 21 | 3 | CID000001216 | |
| Drug | procyclidine | 2.21e-04 | 24 | 21 | 2 | CID000004919 | |
| Drug | intruder | 2.21e-04 | 24 | 21 | 2 | CID000213021 | |
| Drug | anabaseine | 2.21e-04 | 24 | 21 | 2 | CID000018985 | |
| Drug | anabasine | 2.40e-04 | 25 | 21 | 2 | CID000002181 | |
| Drug | pempidine | 2.40e-04 | 25 | 21 | 2 | CID000006603 | |
| Drug | varenicline | 2.40e-04 | 25 | 21 | 2 | CID000170361 | |
| Drug | PrBCM | 2.40e-04 | 25 | 21 | 2 | CID000037396 | |
| Drug | benzquinamide | 2.60e-04 | 26 | 21 | 2 | CID000002342 | |
| Drug | beta-eudesmol | 2.60e-04 | 26 | 21 | 2 | CID000091457 | |
| Drug | curarine | 2.60e-04 | 26 | 21 | 2 | CID000198004 | |
| Drug | imidazolidine | 2.60e-04 | 26 | 21 | 2 | CID000449488 | |
| Drug | methylcarbamylcholine | 2.80e-04 | 27 | 21 | 2 | CID000004136 | |
| Drug | nornicotine | 2.80e-04 | 27 | 21 | 2 | CID000000412 | |
| Drug | benzodiazepine | 2.91e-04 | 142 | 21 | 3 | CID000134664 | |
| Drug | m(7)GpppG | 2.97e-04 | 143 | 21 | 3 | CID000121958 | |
| Drug | echothiophate | 3.02e-04 | 28 | 21 | 2 | CID000010547 | |
| Drug | pentolinium | 3.02e-04 | 28 | 21 | 2 | CID000005849 | |
| Drug | nicardipine | 3.09e-04 | 145 | 21 | 3 | CID000004473 | |
| Drug | pilocarpine- | 3.22e-04 | 147 | 21 | 3 | CID000004819 | |
| Drug | bifemelane | 3.24e-04 | 29 | 21 | 2 | CID000002377 | |
| Drug | bromoacetylcholine bromide | 3.24e-04 | 29 | 21 | 2 | CID000204966 | |
| Drug | carbachol | 3.38e-04 | 688 | 21 | 5 | CID000002551 | |
| Drug | vecuronium | 3.47e-04 | 30 | 21 | 2 | CID000039764 | |
| Drug | methylenedioxydimethylamphetamine | 3.47e-04 | 30 | 21 | 2 | CID000551630 | |
| Drug | oriens | 3.69e-04 | 154 | 21 | 3 | CID000161645 | |
| Drug | tetrahydrodeoxycortisol | 3.71e-04 | 31 | 21 | 2 | CID000010593 | |
| Drug | AC1L1JK6 | 3.71e-04 | 31 | 21 | 2 | CID000005077 | |
| Disease | cognitive disorder (implicated_via_orthology) | 6.54e-06 | 6 | 20 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 6.54e-06 | 6 | 20 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | nicotine dependence (implicated_via_orthology) | 2.87e-05 | 12 | 20 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | childhood trauma measurement, smoking behaviour measurement | 4.25e-04 | 45 | 20 | 2 | EFO_0005671, EFO_0007979 | |
| Disease | monokine induced by gamma interferon measurement | 5.67e-04 | 52 | 20 | 2 | EFO_0008236 | |
| Disease | irritable bowel syndrome symptom measurement | 7.05e-04 | 58 | 20 | 2 | EFO_0021536 | |
| Disease | schizophrenia (implicated_via_orthology) | 9.68e-04 | 68 | 20 | 2 | DOID:5419 (implicated_via_orthology) | |
| Disease | orofacial cleft, sex interaction measurement | 1.54e-03 | 86 | 20 | 2 | EFO_0008343, MONDO_0000358 | |
| Disease | Visual seizure | 2.12e-03 | 101 | 20 | 2 | C0270824 | |
| Disease | Epileptic drop attack | 2.12e-03 | 101 | 20 | 2 | C0270846 | |
| Disease | Generalized seizures | 2.12e-03 | 101 | 20 | 2 | C0234533 | |
| Disease | Clonic Seizures | 2.12e-03 | 101 | 20 | 2 | C0234535 | |
| Disease | Vertiginous seizure | 2.12e-03 | 101 | 20 | 2 | C0422855 | |
| Disease | Gustatory seizure | 2.12e-03 | 101 | 20 | 2 | C0422854 | |
| Disease | Seizures, Somatosensory | 2.12e-03 | 101 | 20 | 2 | C0422850 | |
| Disease | Olfactory seizure | 2.12e-03 | 101 | 20 | 2 | C0422853 | |
| Disease | Seizures, Auditory | 2.12e-03 | 101 | 20 | 2 | C0422852 | |
| Disease | Generalized Absence Seizures | 2.12e-03 | 101 | 20 | 2 | C4505436 | |
| Disease | Convulsive Seizures | 2.12e-03 | 101 | 20 | 2 | C0751494 | |
| Disease | Seizures, Sensory | 2.12e-03 | 101 | 20 | 2 | C0751496 | |
| Disease | Atonic Absence Seizures | 2.12e-03 | 101 | 20 | 2 | C0751123 | |
| Disease | Complex partial seizures | 2.12e-03 | 101 | 20 | 2 | C0149958 | |
| Disease | Single Seizure | 2.12e-03 | 101 | 20 | 2 | C0751110 | |
| Disease | Epileptic Seizures | 2.12e-03 | 101 | 20 | 2 | C4317109 | |
| Disease | Jacksonian Seizure | 2.12e-03 | 101 | 20 | 2 | C0022333 | |
| Disease | Non-epileptic convulsion | 2.12e-03 | 101 | 20 | 2 | C0751056 | |
| Disease | Nonepileptic Seizures | 2.12e-03 | 101 | 20 | 2 | C3495874 | |
| Disease | Tonic Seizures | 2.16e-03 | 102 | 20 | 2 | C0270844 | |
| Disease | Absence Seizures | 2.16e-03 | 102 | 20 | 2 | C4316903 | |
| Disease | Convulsions | 2.16e-03 | 102 | 20 | 2 | C4048158 | |
| Disease | Seizures, Focal | 2.24e-03 | 104 | 20 | 2 | C0751495 | |
| Disease | Myoclonic Seizures | 2.24e-03 | 104 | 20 | 2 | C4317123 | |
| Disease | Tonic - clonic seizures | 2.24e-03 | 104 | 20 | 2 | C0494475 | |
| Disease | Schizophrenia | 2.63e-03 | 883 | 20 | 4 | C0036341 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GKLLWRKFQIPRFMP | 16 | Q9Y2D0 | |
| HKPWRLGPRFMNLIK | 351 | P39086 | |
| LPPYKRWHELMLDKA | 56 | Q13510 | |
| MGTLPARRHIPPWVK | 1 | A6NC42 | |
| PRLKRKKPFHWLPSI | 256 | Q9NVE4 | |
| WFLRMKRPGEDKVRP | 341 | P36544 | |
| MKVWLPLFPRDHRKP | 746 | Q4ADV7 | |
| QKKDCVPLMKPHRPW | 31 | Q9UBX0 | |
| WFLRMKRPGEDKVRP | 251 | Q494W8 | |
| HPAVKFPCGRPWKRM | 176 | P04070 | |
| PRHPVVMWRMKAPAK | 841 | Q9UI47 | |
| FRPPLRKPGKWCAMH | 76 | Q9HAH7 | |
| WLKEGPPAHKLEMPR | 726 | Q5T890 | |
| HRPEAAPPVLKMWKL | 1261 | A6NES4 | |
| KYPRLWCMTKPPSRR | 276 | Q9NRC8 | |
| WCMTKPPSRRPKLYI | 281 | Q9NRC8 | |
| LHPVKKWPMRSRLYI | 126 | Q7RTU0 | |
| LWHMFKPPPALECRR | 1281 | O75116 | |
| WAGRKIRPLPPMKSY | 281 | Q5T653 | |
| PHFWPKLLMKEREVQ | 361 | P10827 | |
| RGLRYLHPLKKWPMR | 146 | Q7RTU1 | |
| PLRPPKMKFITEIWH | 66 | P62253 |